Clinical Trials in Ohio

Showing 7561-7580 of 20,938 trials

Parental Perceptions on Prescription Opioid Use

NCT05344118

This study involves an anonymous survey given to parents regarding their perceptions on prescription opioid use for pain control in children undergoing orthopedic surgery.

Orthopedic Disorder

Nationwide Children's Hospital125 participantsStarted Mar 2022

Columbus, Ohio, United States

COMPLETEDPhase 232 miles

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

NCT04731675

AMB-051-01 is a multicenter study with an adaptive design that will enroll subjects with Tenosynovial Giant Cell Tumor (TGCT) of the knee for 12 weeks of multiple-dose, open-label treatment with intra-articular AMB-05X.

Tenosynovial Giant Cell TumorPigmented Villonodular Synovitis (PVNS)

AmMax Bio, Inc.11 participantsStarted May 2021

Columbus, Ohio, United States • Leiden, Netherlands • Warsaw, Poland +3 more locations

COMPLETED32 miles

TRC-PAD Program: In-Clinic Trial-Ready Cohort

NCT04004767

The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known biomarker status may have direct referral to the Trial-Ready Cohort. If you are interested in being selected for the TRC-PAD study, you should first enroll in the APT Webstudy (https://www.aptwebstudy.org/welcome).

Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease+1 more

University of Southern California220 participantsStarted Jun 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +42 more locations

Parental Perceptions on Prescription Opioid Use

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Find Trials by Condition in Ohio

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Efficacy of Ginseng for Patients on Regorafenib

Evaluating an eHealth Solution for Screening in Pediatric Care

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

Fibricheck Detection cApabilities for Atrial Fibrillation

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout